Markt oder Branche auswählen:
Chart-Typ:
Zeitraum:
| Telix Pharma FY25 Adj. EBITDA Declines; Revenue Up 56% | CANBERA (dpa-AFX) - Telix Pharmaceuticals (TLX, TLX.AX) reported a fiscal 2025 loss before income tax of $5.3 million compared to profit of $38.0 million, prior year. The company noted that... ► Artikel lesen |
| Telix Pharmaceuticals Limited: FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment | MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended December... ► Artikel lesen |
| Telix Submits European Marketing Authorization Application For TLX101-Px | CANBERA (dpa-AFX) - Telix Pharmaceuticals Limited (TLX) has submitted a marketing authorization
application in Europe for TLX101-Px, its glioma imaging candidate. The submission covers major... ► Artikel lesen |
| Pan African Resources Plc - Pan African to acquire Emmerson Resources | Pan African Resources Plc - Pan African to acquire Emmerson Resources
PR Newswire
LONDON, United Kingdom, March 09
Pan... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.